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Neurofibromatosis Type 1 (NF1) is a progressive genetic disorder characterized mainly
by café-au-lait macules, Lisch nodules, as well as cutaneous and subcutaneous neurofibromas
among other traits. Due to the physical manifestations of the condition, it has been observed that
individuals with NF1 have lower self-esteem (SE) when compared to the general population.
Additionally, a study published over 20 years ago found that overall knowledge of NF1 was poor
in individuals affected with the condition. The goal of our study was to reassess knowledge in
this population and investigate whether it is related to SE. A survey comprised of knowledgebased questions and the Rosenberg Self-Esteem Scale was distributed to individuals with NF1
through the Texas NF Foundation. Overall, the 49 respondents (13 to 73 years old) had higher
than expected knowledge of NF1 (mean score = 77.9% correct answers) across various aspects
of the condition. Consistent with previous studies, the SE of our study population was lower
compared to general population norms. Although there was no correlation detected between
knowledge and SE, SE scores were on average higher if a person reported to have friends with
NF1, attended an NF1 support group, attended a NF clinic, or received genetic counseling.
Having friendships with people who have the same condition as well as attending support groups
may help those affected by NF1 to feel less isolated. Additionally, genetic counseling provides
an opportunity for these individuals to potentially identify ways to improve coping through
positive coping strategies such as educating peers about NF1.
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Introduction
Neurofibromatosis Type I (NF1) is a progressive genetic disorder caused by a mutation in
the tumor suppressor gene, NF1. It affects around 1 in 2500 to 3000 individuals. Clinical
manifestations of NF1 include multiple café au lait macules, axillary and inguinal freckling,
neurofibromas, and Lisch nodules. Additionally, individuals can have plexiform neurofibromas,
optic gliomas affecting vision, malignant cancers, skeletal problems, and hypertension (Williams
et al., 2009). Children and adolescents can also experience learning and peer problems at school
as a result of their diagnosis (Krab et al., 2008). Approximately 35% to 65% of patients with
NF1 have learning difficulties, which include deficits in reading, mathematics, language, and
memory (Levine, Materek, Abel, O’Donnell, & Cutting, 2006). Approximately 6-7% of people
with NF1 have an IQ score under 70 and are considered to have mild intellectual disability
(Lehtonen, Howie, Trump, & Huson, 2013). In addition, 50% of people with NF1 have attentiondeficit hyperactivity disorder (ADHD) (Levine et al.).
The negative effects of NF1on cognitive abilities and physical appearance have
motivated researchers to assess the quality of life (QoL) in affected children and adults. One such
study with an adult French cohort investigated QoL through the use of a general health
questionnaire (Short Form 36, SF-36) and a skin disease-specific questionnaire (Skindex). They
found that the emotional consequences such as depression, fear, embarrassment, and anger about
the condition were the most prevalent negative outcomes in affected individuals. Furthermore,
there was a greater negative impact on QoL in people with a more visible form of the disorder or
in those with more severe medical problems related to NF1 (Wolkenstein, Zeller, Revus, Ecosse,
& Leplege, 2001; Chren, 2012). These same measures (SF-36 and Skindex) were also applied in
an American cohort with similar results; however, they found that women were more likely to
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experience emotional effects of the condition than men (Page et al., 2006). Similarly, a study
revealed that children and adolescents with NF1 have impaired QoL, affecting areas of motor,
cognitive, and social functioning (Graf, Landolt, Mori, & Boltshauser, 2006). Another study
looking at emotional functioning of patients with neurofibromatosis (including individuals with
NF1, NF2, or schwannomatosis) found that these individuals were more likely to experience
depression and anxiety because of their diagnosis. Additionally, the study population was found
to have lower self-esteem on average, when compared to the general population (Wang et al.,
2012).
Although there have been numerous studies on QoL of individuals with NF1, Benjamin
et al. (1993) is the only study that has investigated level of knowledge of NF1 in those with the
condition. They found that there was an overall poor understanding of the condition in
individuals with NF1. In fact, knowledge seemed to be reflective of, and even limited to, the
patient’s personal and/or family’s experience with NF1. Factors associated with having a greater
level of knowledge of the disorder were: having received genetic counseling, belonging to a
higher social class, being diagnosed at a young age, being a member of a support group, having a
child with NF1, and when NF1 had influenced reproductive decisions (Benjamin et al., 1993).
The current study reassessed knowledge of NF1 in patients with the condition and
measured their self-esteem using the Rosenberg Self-Esteem Scale (RSES). Correlations
between knowledge scores and self-esteem levels were investigated to evaluate associations
between having a good understanding of the condition and the potential effect on self-esteem.
Additionally, other factors, such as support group involvement, or a family history of NF1 were
also explored, to determine if there were any correlations with knowledge and/or self-esteem.
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Methodology
Participants
Approval for this study was received by the Committee for the Protection of Human
Subjects (CPHS)—The University of Texas Health Science Center at Houston Institutional
Review Board (IRB Number: HSC-GEN-14-0596).
The study population consisted of individuals aged 13 years and older with a clinical
and/or molecular diagnosis of NF1. The participants were accessed through the Texas NF
Foundation, either through their electronic mail (email) database, Facebook group, or at a
foundation-sponsored event.
Instrumentation
There was an online and paper version of the questionnaire. The online version was
created using REDCap software version 5.9.11. The questionnaire had three main sections: (1)
demographic questions, as well as questions focusing on the respondents’ experience with NF1,
(2) knowledge of NF1, and (3) the Rosenberg Self-Esteem Scale (RSES). The demographic
information collected included: gender, current age, age of diagnosis, ethnicity, educational
background, and employment status. In the knowledge section, respondents were asked to: 1)
identify symptoms of NF1 from those of tuberous sclerosis complex (TSC), 2) answer true and
false questions regarding the variability and progressiveness of the condition, and 3) answer
multiple choice questions about the genetics, recurrence risk, incidence, and management of
people with NF1. Section 3 of the survey consisted of the Rosenberg Self-Esteem Scale (RSES),
which is a validated tool that consists of 10 questions that evaluates a person’s self-esteem. Each
question is graded on a Likert scale with total scores ranging from 0 to 30. Higher scores indicate
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better self-esteem, while scores less than 15 are associated with low self-esteem and scores
between 15 and 25 with average or normal level self-esteem (Rosenberg, 1989).
Procedures
The Texas NF Foundation sent out an email to all their members (approximately 1600)
on November 4, 2014 to invite them to participate in the survey. The email consisted of an
invitation letter to participate in the survey as well as a link to the survey. Two reminder emails
were sent out in December and January. The survey was available for the participants to
complete for approximately three months until February 1, 2015 when data collection ended. The
database only included email addresses of adults (over the age of 18 years) with NF1 and the
parents of individuals under the age of 18 with NF1. A link to the survey was also posted on the
Facebook page of the Texas NF Foundation. Additionally, hardcopy questionnaires were
distributed at a foundation-sponsored holiday event, Cookies with Santa, on December 7, 2014.
Parental consent was obtained for participants under the age of 18 years. For the online
version of the questionnaire, parents were prompted to read the consent form and decide whether
they wanted their child to participate in the study. If the parent agreed, then the child was
instructed to read the consent form and indicate whether or not he/she wanted to participate.
Adults with NF1 indicated consent by agreeing to opt-in to the study prior to beginning the online questionnaire. For the hardcopy version, individuals were asked to read an informed consent
document and then provide their signature if they agreed to participate.
Data Analysis
Knowledge scores were calculated by counting each correct answer as one point. The
total number of knowledge questions was 35; therefore the highest possible score was a 35/35.
The knowledge score was reported as a percentage correct for each participant. Self-esteem
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scores were calculated based on the Rosenberg scale methodology (Rosenberg, 1989). Pearson’s
correlation coefficients were calculated to assess the relationship between the continuous
variables for knowledge and self-esteem. A two-sample unpaired t-test was used to examine
potential difference in knowledge score between those in the “low” self-esteem group and those
in the “average or above-average” self-esteem group. Two-sample unpaired t-tests were also
used to examine potential relationships between one’s background or experience with NF1 and
that person’s level of knowledge or self-esteem. A Mann-Whitney test was used to compare the
participant’s knowledge score to whether or not they thought they would be able to explain NF1
to a friend. Two-sample tests of proportions were used to compare the knowledge results of the
current study to the knowledge results of Benjamin et al. Multivariable linear regression models
were fitted to assess the independent effect of various factors on knowledge and self-esteem. All
analyses were performed using STATA (v.13.0, College Station, TX). Statistical significance
was assumed at a Type I error rate of 0.05.
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Results
Study Participants
A total of 115 partial or complete responses were collected through REDCap and 2
complete responses were collected at the Cookies with Santa event. Of the 115 online responses,
48 (42%) respondents had completed all of the relevant sections necessary for inclusion in
analysis. One respondent was under the age of 13 and did not meet eligibility criteria and was
therefore excluded. The final study population comprised of 49 participants.
The participants’ ages ranged from 13 to 73, with four under the age of 18. The mean age
of respondents was 39.2 years (SD: 16.9). While 42 (86%) of the participants indicated that they
knew the age at which they were diagnosed with NF1, only 39 of those (93%) provided the age.
The median age of diagnosis was 4 years (range <1 year through 34 years).
The majority of the participants identified themselves as non-Hispanic white (61%)
followed by Hispanic white at 20%. Approximately two-thirds of the study population had
completed graduate school or professional school, college, or some college. Complete
demographic information is summarized in Table 1.
A large proportion of the participants (n=37, 76%) reported problems with learning in
school, with 32% of those individuals requiring special education classes. Additionally, 57% of
the study population reported difficulty paying attention and 23% reported an official diagnosis
of Attention-Deficit Hyperactivity Disorder (ADHD) (Table 2). Participants who reported
having learning problems were found to have lower self-esteem (p=0.023) (Table 3).
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Table 1 Demographics
Mean age (N=49)

39 years

Median age of diagnosis (N=39)

4 years

Gender (N=49)
Male
Female

n (%)
17 (35)
32 (65)

Ethnicity (N=49)
Non-Hispanic white
Hispanic white
Hispanic/Pacific Islander
Black or African American
Other
No answer

n (%)
30 (61)
10 (21)
3 (6)
2 (4)
2 (4)
2 (4)

Education (N=49)
Still in middle or high school
Did not graduate from high school
Graduated high school or GED
In or graduated from a technical school
Some college
Graduated college (undergraduate degree)
Graduate school or professional school
No answer

n (%)
5 (10)
2 (4)
7 (14)
1 (2)
14 (31)
14 (29)
4 (8)
1 (2)

Table 2 Learning and Attention of Participants (N =49)
Problems learning in school
Yes
No
Don’t know/don’t remember

n (%)
37 (76)
10 (20)
2 (4)

Special education classes
Yes
No
Don’t know/don’t remember

n (%)
12 (25)
36 (73)
1 (2)

Attention problems
Yes
No

n (%)
28 (57)
21 (43)

Diagnosis of ADHD
Yes
No
Don’t know

n (%)
11 (22)
36 (74)
2 (4)
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Table 3 Factors Influencing Self-Esteem
Mean SelfEsteem Score
(Range 0-30)±SD
Do you or did you have problems learning in school?
Yes (n=37)
No (n=10)
Don’t know/Don’t remember (n=2)

18.2±6.7
23.9±5.3
n/a

Do you have any friends with NF1?
Yes (n=13)
No (n=31)
Don’t know (n=2)
Incomplete self-esteem score (n=3)

23.4±5.4
17.7±6.7
n/a
n/a

Have you ever been to a gathering or support group for NF?
Yes (n=28)
No (n=18)
Incomplete self-esteem score (n=3)

21.3±5.5
15.7±7.3
n/a

Have you ever been to a NF clinic (a clinic that specializes in
treating people with NF)?
Yes (n=23)
No (n=21)
Don’t know (n=2)
Incomplete self-esteem score (n=3)

20.8±6.5
16.8±6.6
n/a
n/a

Have you ever had genetic counseling/seen a genetic
counselor?
Yes (n=16)
No (n=28)
Don’t know (n=2)
Incomplete self-esteem score (n=3)

22.4±6.5
16.9±6.2
n/a
n/a

P-value

0.023
n/a

0.009
n/a
n/a

0.006
n/a

0.049
n/a
n/a

0.008
n/a
n/a

Survey Responses
Self-Perceived Severity
Participants were asked questions regarding self-perceived severity of NF1. The majority
(84%) believed that they had a less severe form of the NF1 compared to others with the
condition. While a large proportion (71%) reported NF1 affecting their physical appearance,
overall, respondents were not embarrassed to go out in public because of their diagnosis (78%).
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About half of the study population reported that they had health problems due to their NF1
diagnosis.
Experience with NF1
Participants were asked questions regarding their experience with NF1. Of the 49
respondents, 27% had inherited the condition from a parent (Table 4) and overall, 37% of
respondents reported having a first degree relative with NF1. Among sources of support and
experience with different healthcare professionals, 61% percent reported attending a support
group for NF1, 49% had received care at an NF-specific clinic, and 33% had seen a genetic
counselor or had genetic counseling (Table 5). Respondents were also asked questions regarding
peer relationships and the importance of knowledge; approximately two-thirds of the study
population did not have trouble making friends because of their diagnosis and almost the entire
group (98%) believed that knowing information about NF1 was important (Table 6).
There were several factors associated with higher self-esteem scores: having friends with
NF1 (p=0.009), attending a support group (p=0.006), attending an NF clinic for care (p = 0.049),
and receiving genetic counseling (p=0.008) (Table 3). In addition, individuals who did not think
that they would be able to explain NF1 to a friend had a lower median knowledge score
(p=0.007) and individuals who desired to know more about NF1 also had a lower knowledge
score on average (p=0.043) (Table 7).
Multivariable linear regression models were fitted to determine the independent effects of
having learning problems, having friends with NF1, attending a support group, attending an NF
clinic, and receiving genetic counseling after adjusting for all the other factors. Based on the
regression models, on average, self-esteem scores increased independently by 4.8, 4.7, 4.0, and
4.1 units in the absence of learning problems (95% CI: 1.4 - 8.3), having friends with NF1 (95%
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CI: 0.7-8.7), attending a support group (95% CI: 0.2 - 7.8) or receiving genetic counseling (95%
CI: 0.3 - 7.8), respectively. Although attending a multidisciplinary clinic was significantly
associated with self-esteem in univariable analyses, this factor was not significantly associated in
the multivariable models.

Table 4 Experience with NF1: First Degree Relatives
Yes
n (%)
Do you have a parent with NF1?
13 (27)

No
n (%)
32 (65)

Don’t know
n (%)
4 (8)

No answer
n (%)
0

Do you have brothers or sisters with NF1?

4 (8)

42 (86)

3 (6)

0

Do you have a child with NF1?

9 (18)

39 (80)

1 (2)

0

Table 5 Experience with NF1: Support and Healthcare
Yes
n (%)
Do you have any friends with NF1?
14 (29)

No
n (%)
33 (67)

Don’t know
n (%)
2(4)

No answer
n (%)
0

Have you ever been to a gathering/support
group for NF?

30 (61)

19 (39)

0

0

Have you ever had counseling/seen a
therapist because of having NF1?

8 (16)

40 (82)

1 (2)

0

Have you ever had neuropsychological
testing (tests that measure intellectual
ability)?

16 (33)

29 (59)

3 (6)

1 (2)

Have you ever been to a NF clinic (a clinic
that specializes in treating people with NF)?

24 (49)

23 (47)

2 (4)

0

Have you ever had genetic counseling/seen
a genetic counselor?

16 (33)

31 (63)

1 (2)

1 (2)
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Table 6 Experience with NF1: Peer Relationships and Knowledge
Yes
No
n (%)
n (%)
Have you ever been bullied because you
22 (45)
22 (45)
have NF1?

Don’t know
n (%)

No answer
n (%)

5 (10)

0

Do you think you have trouble making
friends because of having NF1?

12 (25)

34 (69)

3 (6)

0

Do you think that your friends and other
people understand what NF1 is?

9 (18)

37 (76)

3 (6)

0

Do you think you would be able to explain
NF1 to a friend?

72 (86)

5 (10)

2 (4)

0

Do you wish you knew more about NF1 so
that you could explain it better to people?

34 (69)

14 (29)

1 (2)

0

Do you think it’s important to know
information about NF1?

48 (98)

1 (2)

0

0

Table 7 Factors Influencing Knowledge Scores
Median Knowledge Score (%)
Do you think you would be able to
explain NF1 to a friend?
Yes (n=42)
80.0
No (n=5)
68.6
Don’t know (n=2)
n/a

P-value

0.0066
n/a

Mean Knowledge Score (%)±SD
Do you wish you knew more about
NF1 so that you could explain it better
to people?
Yes (n=34)
No (n=14)
Don’t know (n=1)

76.4±7.6
82.0±10.7
n/a

0.0428
n/a
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Knowledge
Participants were asked to identify the features associated with NF1. Overall, correct
identification of the features was high with several features correctly identified over 80% of the
time, such as, café au lait macules, neurofibromas, learning problems, freckling in axillary and
inguinal regions, and bone problems. Compared to Benjamin et al. (1993), we saw a statistically
significant improvement in knowledge of the following features: cancers, macrocephaly, Lisch
nodules, freckling, bone problems, and learning issues (Figure 1).

Figure 1: Features of NF1
Hypertension
Cancers*
Optic gliomas
Macrocephaly*
Lisch nodules*
Freckling*
Bone problems*
Learning issues*
Neurofibromas
Café au laits
Current Study

0

20

40
60
Percentage Correct

Benjamin et al., 1993

80

100
* p-value < 0.000

Participants were asked a series of true and false questions. Ninety-eight percent of the
study population correctly understood that it is not their fault that they have NF1. There was also
high knowledge of the variability of the condition, with 93.9% understanding that NF1 could
vary within and between families. The more severe outcomes of NF1, such as cancers and
blindness, had the lowest correct scores (Table 8).
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Table 8 True and False Section
Correct
answer

Correct
responses
(%)

It is a person’s fault if they have NF1.

False

98

If multiple family members have NF1, then they will all have the same
amount of lumps and brown marks and will have the same health problems.

False

94

Often, people with NF1 from different families will have different symptoms.

True

94

Brown marks (café au laits) are often the first sign that a person has NF1.

True

86

NF1 physical features get better as a person gets older.

False

82

Half of patients with NF1 have a family history of NF1.

True

78

A person with NF1 can develop cancer that causes them to die.

True

67

A person with NF1 can develop a cancer that causes them to be blind.

True

59

Question

There were several other questions covering additional aspects of the condition. Ninetysix percent of individuals knew that NF1 was caused by a mutation in a gene, although only
61.2% knew the function of the NF1 gene. Additionally, 90% chose the correct recurrence risk
and 76% understood that the recurrence risk is the same for each pregnancy. Complete results of
the multiple-choice section can be found in Table 9. Compared to Benjamin et al. (1993), we
observed a significant increase in knowledge of intrafamilial and interfamilial variability and
recurrence risk of the condition (Figure 2). Overall, we observed good understanding across the
majority of the knowledge section, with an average score of 77.9% (SD: 8.8) correct answers.
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Table 9 Multiple Choice Section
What causes NF1?
A mutation in a gene
An infection
Being in the sun too much
Having an allergic reaction to
food?
Don’t know
If a person with NF1 has a child, what is
the chance that the child will have NF1?
0% chance
10% chance

n (%)
47 (96)
0
0
0
2 (4)

0
1 (2)
44 (90)

100% chance
Don’t know

1 (2)
3 (6)

About how many people have NF1?
1 in 300

40 (82)
5 (10)

Men
Women
NF1 affects both men and
women equally
Don’t know

1 (2)
1 (2)
42 (86)
5 (10)

3 (6)

A skin exam

3 (6)

2 (4)

Brain imaging (MRI)

2 (4)

37 (76)

Eye exam

7 (14)

All of the above

2 (4)
0

1 in 3,000

35 (71)

1 in 30,000

4 (8)

Don’t know

8 (16)

This is a cure for NF1.

Taking certain medicine
There is no cure
Don’t know

0
0
4 (8)

A person diagnosed with NF1 usually has
this/these test(s) done:

1 in 1,000

Surgery

n (%)

Are men or women more affected by NF?

50% chance

If a person with NF1 has a child with
NF1, what is the chance that a second
child will have the condition?
The chance is much higher to
have another child with NF1
The chance is much lower to
have another child with NF1
The chance to have another
child with NF1 does not change
Don’t know

What group of people is most affected by
NF?
Asian
Black/African American
White/Caucasian
NF1 affects all groups of people
equally
Don’t know

0
0
48 (98)
1 (2)

What function does the NF1 gene have?
Determines a person’s eye color
Determines if a person will be a
good athlete
Helps the body break down sugar
Keeps tumors from growing in
the body
Don’t know
How can NF1 be diagnosed?
If a patient has enough features
of NF1 (clinical diagnosis)
With genetic testing
Both a and b
Don’t know

0
44 (90)
0
0
1 (2)
30 (61)
18 (37)

9 (18)
2 (4)
38 (78)
0
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Figure 2: Knowledge of Recurrence Risk, Variability, and Progressiveness
Recurrence risk for 2nd child*
Progressive condition
Males v females*
Recurrence risk*
Intrafamilial variability*
Interfamilial variability*
Current Study

0

Benjamin et al., 1993

20

40
60
Percentage Correct

80

100

Rosenberg Self-Esteem Scale
Complete self-esteem scores were collected for 46 (93.9%) of the participants. Of these
individuals, 21.7% had low self-esteem scores (<15) with an average score of 9.5, 56.6% had
average/normal self-esteem scores (15-25) with an average score of 19.1, and 21.7% had aboveaverage self-esteem scores (>25) with an average score of 28.6. The average self-esteem score of
the study population was lower compared to general population norms (p=0.0001) (Sinclair,
Blais, Gansler, Sandberg, Bistis, & LoCicero, 2010). The study population was also stratified by
gender and compared to the general population norms; both males and females had lower
average self-esteem scores compared to the general population (p=0.0432 and p=0.0006,
respectively) (Table 10).

Table 10 Comparison of Self-Esteem Scores to General Population Norms
Study Population
General Population*
n
Mean ±SD
n
Mean ±SD
Overall
46
19.09 ±6.77
503
22.62 ±5.80
Gender
Male
17
19.29 ±5.31
242
22.43 ±6.21
Female
29
18.97 ±7.58
261
22.79 ±5.41

t value

P- value

3.89

0.0001

2.03
3.45

0.0432
0.0006

*General population norms taken from Sinclair, Blais, Gansler, Sandberg, Bistis, & LoCicero, 2010
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Discussion
Knowledge of NF1
This study aimed to assess knowledge about NF1 and self-esteem in individuals with
NF1. We identified changing trends in the knowledge of individuals with NF1 and identified
other factors associated with knowledge and self-esteem in these individuals.
Compared to the Benjamin study done in 1993, knowledge of NF1 seems to have
improved in individuals with the condition. Correct identification of features was high in the
current study and showed improvements from the previous study. For example, 90% of
participants correctly identified freckling in the inguinal and axillary areas as a feature of NF1
compared to only 10% in the previous study (Benjamin et al., 1993). Additionally, knowledge of
recurrence risk was higher with 88% of our study population identifying the correct recurrence
risk of 50% in a multiple choice question. We used true and false questions to ask about the
variability of the condition and found a stark difference between the two studies, with 94% of the
respondents in the present study understanding that NF1 could vary within and between families
compared to the previous study which showed that only 33% knew it could vary between
families and 34% knew it could vary within a family (Benjamin et al., 1993). Of note, the
previous study used an interview-based questionnaire in which the majority of the questions
were open-ended.
There are several possible reasons for this apparent increase in knowledge of NF1. First,
there are more patient-friendly educational materials available today compared to 20 years ago.
For example, in 2005 the Texas NF Foundation (TNFF) published an educational storybook, 14
Stories, for newly diagnosed patients and their families (http://texasnf.org/). Second, there has
been improved availability of the internet over the last couple of decades, making access to
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information about NF1 easier. Third, there is likely greater patient awareness of the condition
through membership in support group organizations like the TNFF. The TNFF mails out packets
of information if requested and directs members to reliable online resources including their web
page. The organization’s educational goal is to get accurate information about NF1 into the
hands of their members (C. Hahn, personal communication, April 3, 2015). The TNFF has ample
resources for families affected by NF available on their website and membership in the
organization is not required to access this information (http://texasnf.org/). In addition, in the
phenomenon of “patient activation,” or patients playing a more active role in their healthcare,
which requires knowledge of one’s condition, could be in effect. This may be influenced in part
by the patient’s relationship with his or her physician. Traditionally, the physician had a more
paternalistic role, while the patient was more passive about their healthcare. However, there has
been a shift to a more collaborative relationship between the patient and the physician
(Alexander, Hearld, Mittler, & Harvey, 2012).
Lower knowledge scores were seen in participants who reported they would have
difficulty explaining NF1 to a friend and in those who desired to gain more knowledge about
NF1 so that they could explain it better to others. These findings were not surprising as we would
expect those who are having trouble explaining NF1 to others to desire to know more about the
condition. The majority (98.0%) of the study population expressed that it was important to learn
information about NF. This stresses the importance of continually striving to make educational
resources readily available to the NF community.
We hypothesized that individuals with greater knowledge of NF1 would have higher selfesteem. However, we did not find any association between the two factors. Perhaps knowledge
itself is not enough to boost self-esteem, but instead it is the use of knowledge in interactions
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with others that can help to reduce stigma, which could potentially have the positive impact of
improved self-esteem. Knowledge of one’s condition may be beneficial in being better able to
educate others about NF1 and combat stigma associated with a diagnosis of NF1. Education, or
teaching peers about a disorder, has been identified in previous studies as a coping strategy to
combat stigma, in addition to the coping strategies of secrecy (hiding one’s condition) and
withdrawal (avoiding social or professional situations) (Peters et al., 2005). In a study on
individuals with Marfan syndrome coping with stigma, it was demonstrated that 51% of
individuals used educating others as a coping strategy. It was also observed that those who used
“withdrawal” or “secrecy” as coping strategies tended to have lower self-esteem and experience
more symptoms of depression (Peters et al., 2005). Furthermore, several studies demonstrate that
the use of “preventive disclosure” of a chronic diagnosis to peers is helpful in minimizing
negative peer views (Troster, 1997; Berlin, Sass, Davies, Jandrisevits, & Hains, 2005; Marcks,
Berlin, Woods, & Davies, 2007). These studies do not take into consideration the individuals’
level of knowledge of the particular condition, which could influence the tendency to selfdisclose. Although we did not investigate what coping methods were most frequently used by the
study population, further studies on stigmatization of the NF population are necessary in order to
elucidate the most helpful coping strategies for these individuals.
Factors Influencing Self-Esteem
The results of this study are consistent with previous reports of lower self-esteem in
individuals with NF compared to the general population (Wang et al., 2012). Having a history of
learning problems was correlated with lower self-esteem. This indicates that perhaps the
visible/cosmetic effects of NF1 are not the sole cause of lower self-esteem in this population, but
that the cognitive effects of the condition also play a major role. The results of Martin et al.
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(2012) suggested that impaired cognitive abilities may negatively impact emotional well-being in
individuals with NF1. There are no known studies that have looked specifically at the impact of
learning disabilities on self-esteem. Moreover, several factors were observed to have a positive
influence on self-esteem: having friends with NF1, attending a support group, attending a NF
clinic, or receiving genetic counseling. We suspect that having friendships with others who have
the same diagnosis can help reduce feelings of isolation and lead to an increase in self-esteem.
Similarly, involvement in support groups help improve confidence of members by providing
long-term support and making individuals affected with a genetic condition or families of
affected individuals feel less isolated (“Psychological & Social Implications,” 2010). Most
support groups also aim to provide accurate information to their members about the specific
condition and the associated genetic risk. Therefore, parental participation in support groups can
have the positive effect of making a family be more open to talking about the genetic condition,
which helps with family coping overall (Plumridge, Metcalfe, Coad, & Gill, 2011).
Improved coping techniques in people who have seen a genetic counselor may partially
explain the higher self-esteem scores seen in our study. Genetic counselors are taught to be
aware of stigma associated with genetic conditions so as to avoid adding to stigmatization
unintentionally (McCarthy Veach, LeRoy, & Bartels, 2003). Furthermore, they are proficient in
helping patients with genetic conditions “understand and adapt to the medical, psychological,
and familial implications of genetic contributions to disease,” (Resta et al., 2006). The genetic
counseling process can provide an avenue for a person with NF1 to explore what coping
mechanisms they have developed as a result of their diagnosis or perhaps identify ways to
improve coping (Gaff & Clarke, 2007). The specialized skills that genetic counselors have may
play an important role in helping people with NF1 learn positive ways to cope with their
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diagnosis, as well as give the person room to express their concerns about NF1 and how it affects
their relationships with others.
Studies have found that medical personnel can be a source of stigma for individuals with
chronic conditions (Ablon, 2002). Perhaps receiving care at a specialized NF clinic, where the
doctors and staff are familiar with the condition, can help to reduce the chance of being judged or
misunderstood by medical professionals. Interestingly, we observed that attending an NF clinic
was correlated with receiving genetic counseling (p=0.001) and attending a support group
(p=0.033). The multivariable models reflected that attending an NF clinic was not independently
associated with an improvement in self-esteem, whereas receiving genetic counseling/seeing a
genetic counselor or attending support groups did positively impact self-esteem. This
underscores the need for genetic counseling and other sources of support for these patients within
and without the multidisciplinary model of care. However, this is not to discount the
multidisciplinary approach for treating NF1 as these clinics provide many benefits to patients
and can be a source of genetic counseling.
Study Limitations
One limitation of our study is that the knowledge portion of the survey has not been
validated. In addition, participants were contacted through a support group organization and were
given the option to participate in the study, creating a selection bias and/or self-selection bias.
However, this could not have been avoided as it is difficult to find cohorts with NF1 using other
recruitment methods. This population may be different from individuals with NF1 who are not
members of a support group, in that they could be more information-seeking or have greater
knowledge of the disease, therefore altering our results. This factor along with our small sample
size limits the ability for our results to be generalized to the NF population as a whole.
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Furthermore, responses to questions about NF1 were based on the “honor system” as it was
impossible to control whether or not a participant looked up answers to questions on the Internet.
In order to discourage the use of the Internet to search for answers to questions and minimize
guessing we provided, “Don’t know” as an option for each question.
Research Recommendations
It would be interesting to investigate the coping strategies used by individuals with NF1
to combat stigmatization and to assess whether increased knowledge of the condition leads to
better coping. While the scope of this study did not include gathering medical information
regarding the severity of the participant’s disease from their physician, collecting this
information would be useful in gaining insight to how severity correlates with self-esteem and
other factors, such as, disclosure of the diagnosis.
Practice Implications
•

Healthcare professionals should encourage patients with NF1 to participate in support
groups like the Texas NF Foundation, in order for them to meet and learn from others
with the condition and to have access to reliable information.

•

Greater effort should be made in the development of multidisciplinary NF clinics
throughout the United States.

•

Referral to a genetic counselor is recommended for individuals and families affected by
NF1.
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